FIELD: medicine.
SUBSTANCE: invention refers to a new agent representing rhodanine derivatives of formula (I), wherein X=N or CH for treating malignant diseases of varying sites.
EFFECT: agent is antiproloferative and antimetastatic action for treating malignant diseases.
3 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
RHODANINE DERIVATIVE AND AGENT FOR PREVENTING MALIGNANT DISEASES | 2013 |
|
RU2521390C1 |
DITHIOCARBAMATE DERIVATIVE, METHOD FOR PRODUCTION THEREOF AND AGENT FOR TREATING OR PREVENTING TUMOUR DISEASES CONTAINING SAID DERIVATIVE | 2011 |
|
RU2502731C2 |
SOLUTION THAT HAVE ANTIPROLIFERATIVE AND ANTIMETASTATIC PROPERTIES FOR ONCOLOGICAL DISEASES TREATMENT | 2016 |
|
RU2678769C2 |
REMEDY WITH ANTI-TUMOR EFFECT FOR TREATMENT OF ONCOLOGICAL DISEASES | 2018 |
|
RU2761429C2 |
AGENT WITH ANTITUMOUR AND ANTIMETASTATIC ACTIVITY, ANTI-INFLAMMATORY AND ANTIALLERGIC ACTION | 2018 |
|
RU2686672C1 |
ANTINEOPLASTIC AGENT | 2016 |
|
RU2623034C1 |
ANTI-INFLAMMATORY MEDICATION WITH ANTICOAGULANT, ANTITUMOUR AND ANTIMETASTETIC ACTIVITY | 2009 |
|
RU2412712C1 |
MEANS OF SIMULTANEOUS PROTECTIVE ACTION IN RELATION TO HEALTHY ORGANS AND TISSUE AND ADJUVANT ACTION IN RADIO AND CHEMOTHERAPY OF TUMOURS | 2015 |
|
RU2646497C2 |
AGENT INCREASING ANTI-METASTATIC ACTIVITY OF CYCLOPHOSPHAN | 2016 |
|
RU2613189C1 |
PHARMACEUTICAL COMPOSITION BASED ON PALLADIUM COMPOUND | 2015 |
|
RU2613305C2 |
Authors
Dates
2014-07-10—Published
2013-03-14—Filed